7 years ago

TestCard Raises $1.7 Million in Seed Funding to Launch At-Home Urine Test Solution

  • TestCard, a London-based healthtech company offering at-home urine test solutions, has secured $1.7 million in seed funding led by Neo Ventures

  • The company intends to use the funds for its initial launch and rollout phase

  • TestCard's service combines a non-invasive urine test kit with a mobile app that uses a phone's camera as a clinical-grade scanner to deliver accurate results

  • The product pipeline includes tests for urinary tract infections, pregnancy, prostate health, diabetes, and kidney disease.

      • ProblemHealthcare

      "TestCard is addressing the need for accurate and convenient at-home urine testing for various health conditions such as urinary tract infections, pregnancy, prostate health, diabetes, and kidney disease."

      Solution

      "TestCard provides a non-invasive urine test kit embedded into a postcard, along with a mobile application that transforms a phone's camera into a clinical-grade scanner for accurate test results at home."

      Covered on